Bibenzyls,a kind of important plant polyphenols,have attracted growing attention for their broad and remarkable pharmacological activities.However,due to the low abundance in nature,uncontrollable and environmentally ...Bibenzyls,a kind of important plant polyphenols,have attracted growing attention for their broad and remarkable pharmacological activities.However,due to the low abundance in nature,uncontrollable and environmentally unfriendly chemical synthesis processes,these compounds are not readily accessible.Herein,one high-yield bibenzyl backbone-producing Escherichia coli strain was constructed by using a highly active and substrate-promiscuous bibenzyl synthase identified from Dendrobium officinale in combination with starter and extender biosynthetic enzymes.Three types of efficiently postmodifying modular strains were engineered by employing methyltransferases,prenyltransferase,and glycosyltransferase with high activity and substrate tolerance together with their corresponding donor biosynthetic modules.Structurally different bibenzyl derivatives were tandemly and/or divergently synthesized by co-culture engineering in various combination modes.Especially,a prenylated bibenzyl derivative(12)was found to be an antioxidant that exhibited potent neuroprotective activity in the cellular and rat models of ischemia stroke.RNA-seq,quantitative RT-PCR,and Western-blot analysis demonstrated that 12 could up-regulate the expression level of an apoptosis-inducing factor,mitochondria associated 3(Aifm3),suggesting that Aifm3 might be a new target in ischemic stroke therapy.This study provides a flexible plug-and-play strategy for the easy-to-implement synthesis of structurally diverse bibenzyls through a modular co-culture engineering pipeline for drug discovery.展开更多
通过将体内稳定同位素标记细胞培养技术(AACT/SILAC)与LC-MS/MS联用,对哺乳动物细胞中TNF-α/NF-κB信号通路相关蛋白在TNF-α及TSA存在情况下乙酰化变化情况进行了研究.在TSA协同处理的、TNF-α刺激的细胞中鉴定到3个乙酰化蛋白,其中...通过将体内稳定同位素标记细胞培养技术(AACT/SILAC)与LC-MS/MS联用,对哺乳动物细胞中TNF-α/NF-κB信号通路相关蛋白在TNF-α及TSA存在情况下乙酰化变化情况进行了研究.在TSA协同处理的、TNF-α刺激的细胞中鉴定到3个乙酰化蛋白,其中核糖体蛋白L4(60SRibosomal Protein L4,RPL4)已被报道存在乙酰化的后修饰,转铁蛋白受体1(Transferrin Receptor Protein 1,TfR1)和凋亡诱导因子3(ApoptosisInducing Factor,Mitochondrion-associated,3,AIFM3)尚未见报道.展开更多
基金supported by the National Key Research and Development Program of China(2020YFA0908000)CAMS Innovation fund for Medical Sciences(CIFMS-2021-I2M1-028 and CIFMS-2021-I2M-1-029,China)Beijing Key Laboratory of non-Clinical Drug Metabolism and PK/PD Study(Z141102004414062,China)。
文摘Bibenzyls,a kind of important plant polyphenols,have attracted growing attention for their broad and remarkable pharmacological activities.However,due to the low abundance in nature,uncontrollable and environmentally unfriendly chemical synthesis processes,these compounds are not readily accessible.Herein,one high-yield bibenzyl backbone-producing Escherichia coli strain was constructed by using a highly active and substrate-promiscuous bibenzyl synthase identified from Dendrobium officinale in combination with starter and extender biosynthetic enzymes.Three types of efficiently postmodifying modular strains were engineered by employing methyltransferases,prenyltransferase,and glycosyltransferase with high activity and substrate tolerance together with their corresponding donor biosynthetic modules.Structurally different bibenzyl derivatives were tandemly and/or divergently synthesized by co-culture engineering in various combination modes.Especially,a prenylated bibenzyl derivative(12)was found to be an antioxidant that exhibited potent neuroprotective activity in the cellular and rat models of ischemia stroke.RNA-seq,quantitative RT-PCR,and Western-blot analysis demonstrated that 12 could up-regulate the expression level of an apoptosis-inducing factor,mitochondria associated 3(Aifm3),suggesting that Aifm3 might be a new target in ischemic stroke therapy.This study provides a flexible plug-and-play strategy for the easy-to-implement synthesis of structurally diverse bibenzyls through a modular co-culture engineering pipeline for drug discovery.
文摘通过将体内稳定同位素标记细胞培养技术(AACT/SILAC)与LC-MS/MS联用,对哺乳动物细胞中TNF-α/NF-κB信号通路相关蛋白在TNF-α及TSA存在情况下乙酰化变化情况进行了研究.在TSA协同处理的、TNF-α刺激的细胞中鉴定到3个乙酰化蛋白,其中核糖体蛋白L4(60SRibosomal Protein L4,RPL4)已被报道存在乙酰化的后修饰,转铁蛋白受体1(Transferrin Receptor Protein 1,TfR1)和凋亡诱导因子3(ApoptosisInducing Factor,Mitochondrion-associated,3,AIFM3)尚未见报道.
